Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia

Mark H. Kuniholm, Andrea Kovacs, Xiaojiang Gao, Xiaonan (Nan) Xue, Darlene Marti, Chloe L. Thio, Marion G. Peters, Norah A. Terrault, Ruth M. Greenblatt, James J. Goedert, Mardge H. Cohen, Howard Minkoff, Stephen J. Gange, Kathryn Anastos, Melissa Fazzari, Tiffany G. Harris, Mary A. Young, Howard Strickler, Mary Carrington

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Studies of human leukocyte antigen (HLA) alleles and their relation with hepatitis C virus (HCV) viremia have had conflicting results. However, these studies have varied in size and methods, and few large studies assessed HLA class I alleles. Only one study conducted high-resolution class I genotyping. The current investigation therefore involved high-resolution HLA class I and II genotyping of a large multiracial cohort of U.S. women with a high prevalence of HCV and HIV. Our primary analyses evaluated associations between 12 HLA alleles identified through a critical review of the literature and HCV viremia in 758 HCV-seropositive women. Other alleles with >5% prevalence were also assessed; previously unreported associations were corrected for multiple comparisons. DRB1*0101 (prevalence ratio [PR] = 1.7; 95% confidence interval [CI] = 1.1-2.6), B*5701 (PR = 2.0; 95% CI = 1.0-3.1), B*5703 (PR = 1.7; 95% CI = 1.0-2.5), and Cw*0102 (PR = 1.9; 95% CI = 1.0-3.0) were associated with the absence of HCV RNA (i.e., HCV clearance), whereas DRB1*0301 (PR = 0.4; 95% CI = 0.2-0.7) was associated with HCV RNA positivity. DQB1*0301 was also associated with the absence of HCV RNA but only among HIV-seronegative women (PR = 3.4; 95% CI = 1.2-11.8). Each of these associations was among those predicted. We additionally studied the relation of HLA alleles with HCV infection (serostatus) in women at high risk of HCV from injection drug use (N = 838), but no significant relationships were observed. Conclusion: HLA genotype influences the host capacity to clear HCV viremia. The specific HLA associations observed in the current study are unlikely to be due to chance because they were a priori hypothesized.

Original languageEnglish (US)
Pages (from-to)1514-1522
Number of pages9
JournalHepatology
Volume51
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Viremia
HLA Antigens
Hepacivirus
Alleles
Confidence Intervals
RNA
HIV
Virus Diseases
Genotype

ASJC Scopus subject areas

  • Hepatology

Cite this

Kuniholm, M. H., Kovacs, A., Gao, X., Xue, X. N., Marti, D., Thio, C. L., ... Carrington, M. (2010). Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology, 51(5), 1514-1522. https://doi.org/10.1002/hep.23515

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. / Kuniholm, Mark H.; Kovacs, Andrea; Gao, Xiaojiang; Xue, Xiaonan (Nan); Marti, Darlene; Thio, Chloe L.; Peters, Marion G.; Terrault, Norah A.; Greenblatt, Ruth M.; Goedert, James J.; Cohen, Mardge H.; Minkoff, Howard; Gange, Stephen J.; Anastos, Kathryn; Fazzari, Melissa; Harris, Tiffany G.; Young, Mary A.; Strickler, Howard; Carrington, Mary.

In: Hepatology, Vol. 51, No. 5, 05.2010, p. 1514-1522.

Research output: Contribution to journalArticle

Kuniholm, MH, Kovacs, A, Gao, X, Xue, XN, Marti, D, Thio, CL, Peters, MG, Terrault, NA, Greenblatt, RM, Goedert, JJ, Cohen, MH, Minkoff, H, Gange, SJ, Anastos, K, Fazzari, M, Harris, TG, Young, MA, Strickler, H & Carrington, M 2010, 'Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia', Hepatology, vol. 51, no. 5, pp. 1514-1522. https://doi.org/10.1002/hep.23515
Kuniholm, Mark H. ; Kovacs, Andrea ; Gao, Xiaojiang ; Xue, Xiaonan (Nan) ; Marti, Darlene ; Thio, Chloe L. ; Peters, Marion G. ; Terrault, Norah A. ; Greenblatt, Ruth M. ; Goedert, James J. ; Cohen, Mardge H. ; Minkoff, Howard ; Gange, Stephen J. ; Anastos, Kathryn ; Fazzari, Melissa ; Harris, Tiffany G. ; Young, Mary A. ; Strickler, Howard ; Carrington, Mary. / Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. In: Hepatology. 2010 ; Vol. 51, No. 5. pp. 1514-1522.
@article{cad3cd66b0a143a7a4b8f40c9b5a283e,
title = "Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia",
abstract = "Studies of human leukocyte antigen (HLA) alleles and their relation with hepatitis C virus (HCV) viremia have had conflicting results. However, these studies have varied in size and methods, and few large studies assessed HLA class I alleles. Only one study conducted high-resolution class I genotyping. The current investigation therefore involved high-resolution HLA class I and II genotyping of a large multiracial cohort of U.S. women with a high prevalence of HCV and HIV. Our primary analyses evaluated associations between 12 HLA alleles identified through a critical review of the literature and HCV viremia in 758 HCV-seropositive women. Other alleles with >5{\%} prevalence were also assessed; previously unreported associations were corrected for multiple comparisons. DRB1*0101 (prevalence ratio [PR] = 1.7; 95{\%} confidence interval [CI] = 1.1-2.6), B*5701 (PR = 2.0; 95{\%} CI = 1.0-3.1), B*5703 (PR = 1.7; 95{\%} CI = 1.0-2.5), and Cw*0102 (PR = 1.9; 95{\%} CI = 1.0-3.0) were associated with the absence of HCV RNA (i.e., HCV clearance), whereas DRB1*0301 (PR = 0.4; 95{\%} CI = 0.2-0.7) was associated with HCV RNA positivity. DQB1*0301 was also associated with the absence of HCV RNA but only among HIV-seronegative women (PR = 3.4; 95{\%} CI = 1.2-11.8). Each of these associations was among those predicted. We additionally studied the relation of HLA alleles with HCV infection (serostatus) in women at high risk of HCV from injection drug use (N = 838), but no significant relationships were observed. Conclusion: HLA genotype influences the host capacity to clear HCV viremia. The specific HLA associations observed in the current study are unlikely to be due to chance because they were a priori hypothesized.",
author = "Kuniholm, {Mark H.} and Andrea Kovacs and Xiaojiang Gao and Xue, {Xiaonan (Nan)} and Darlene Marti and Thio, {Chloe L.} and Peters, {Marion G.} and Terrault, {Norah A.} and Greenblatt, {Ruth M.} and Goedert, {James J.} and Cohen, {Mardge H.} and Howard Minkoff and Gange, {Stephen J.} and Kathryn Anastos and Melissa Fazzari and Harris, {Tiffany G.} and Young, {Mary A.} and Howard Strickler and Mary Carrington",
year = "2010",
month = "5",
doi = "10.1002/hep.23515",
language = "English (US)",
volume = "51",
pages = "1514--1522",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia

AU - Kuniholm, Mark H.

AU - Kovacs, Andrea

AU - Gao, Xiaojiang

AU - Xue, Xiaonan (Nan)

AU - Marti, Darlene

AU - Thio, Chloe L.

AU - Peters, Marion G.

AU - Terrault, Norah A.

AU - Greenblatt, Ruth M.

AU - Goedert, James J.

AU - Cohen, Mardge H.

AU - Minkoff, Howard

AU - Gange, Stephen J.

AU - Anastos, Kathryn

AU - Fazzari, Melissa

AU - Harris, Tiffany G.

AU - Young, Mary A.

AU - Strickler, Howard

AU - Carrington, Mary

PY - 2010/5

Y1 - 2010/5

N2 - Studies of human leukocyte antigen (HLA) alleles and their relation with hepatitis C virus (HCV) viremia have had conflicting results. However, these studies have varied in size and methods, and few large studies assessed HLA class I alleles. Only one study conducted high-resolution class I genotyping. The current investigation therefore involved high-resolution HLA class I and II genotyping of a large multiracial cohort of U.S. women with a high prevalence of HCV and HIV. Our primary analyses evaluated associations between 12 HLA alleles identified through a critical review of the literature and HCV viremia in 758 HCV-seropositive women. Other alleles with >5% prevalence were also assessed; previously unreported associations were corrected for multiple comparisons. DRB1*0101 (prevalence ratio [PR] = 1.7; 95% confidence interval [CI] = 1.1-2.6), B*5701 (PR = 2.0; 95% CI = 1.0-3.1), B*5703 (PR = 1.7; 95% CI = 1.0-2.5), and Cw*0102 (PR = 1.9; 95% CI = 1.0-3.0) were associated with the absence of HCV RNA (i.e., HCV clearance), whereas DRB1*0301 (PR = 0.4; 95% CI = 0.2-0.7) was associated with HCV RNA positivity. DQB1*0301 was also associated with the absence of HCV RNA but only among HIV-seronegative women (PR = 3.4; 95% CI = 1.2-11.8). Each of these associations was among those predicted. We additionally studied the relation of HLA alleles with HCV infection (serostatus) in women at high risk of HCV from injection drug use (N = 838), but no significant relationships were observed. Conclusion: HLA genotype influences the host capacity to clear HCV viremia. The specific HLA associations observed in the current study are unlikely to be due to chance because they were a priori hypothesized.

AB - Studies of human leukocyte antigen (HLA) alleles and their relation with hepatitis C virus (HCV) viremia have had conflicting results. However, these studies have varied in size and methods, and few large studies assessed HLA class I alleles. Only one study conducted high-resolution class I genotyping. The current investigation therefore involved high-resolution HLA class I and II genotyping of a large multiracial cohort of U.S. women with a high prevalence of HCV and HIV. Our primary analyses evaluated associations between 12 HLA alleles identified through a critical review of the literature and HCV viremia in 758 HCV-seropositive women. Other alleles with >5% prevalence were also assessed; previously unreported associations were corrected for multiple comparisons. DRB1*0101 (prevalence ratio [PR] = 1.7; 95% confidence interval [CI] = 1.1-2.6), B*5701 (PR = 2.0; 95% CI = 1.0-3.1), B*5703 (PR = 1.7; 95% CI = 1.0-2.5), and Cw*0102 (PR = 1.9; 95% CI = 1.0-3.0) were associated with the absence of HCV RNA (i.e., HCV clearance), whereas DRB1*0301 (PR = 0.4; 95% CI = 0.2-0.7) was associated with HCV RNA positivity. DQB1*0301 was also associated with the absence of HCV RNA but only among HIV-seronegative women (PR = 3.4; 95% CI = 1.2-11.8). Each of these associations was among those predicted. We additionally studied the relation of HLA alleles with HCV infection (serostatus) in women at high risk of HCV from injection drug use (N = 838), but no significant relationships were observed. Conclusion: HLA genotype influences the host capacity to clear HCV viremia. The specific HLA associations observed in the current study are unlikely to be due to chance because they were a priori hypothesized.

UR - http://www.scopus.com/inward/record.url?scp=77951466879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951466879&partnerID=8YFLogxK

U2 - 10.1002/hep.23515

DO - 10.1002/hep.23515

M3 - Article

VL - 51

SP - 1514

EP - 1522

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -